Diagnosis of Myasthenia Gravis
The diagnosis of myasthenia gravis requires a combination of clinical evaluation, serological testing for specific antibodies, and electrodiagnostic studies, with anti-acetylcholine receptor (AChR) antibody testing being the primary diagnostic test for confirmation.
Clinical Presentation
- Fatigable or fluctuating muscle weakness, typically more proximal than distal, is the hallmark clinical presentation of myasthenia gravis 1
- Ocular symptoms (ptosis, diplopia) are common initial manifestations, with generalization to other muscle groups occurring in approximately 80% of cases 2
- Bulbar involvement may present as dysphagia, dysarthria, and facial muscle weakness 1
- Symptoms worsen with repeated use of affected muscles and improve with rest 3
Primary Diagnostic Tests
- Anti-acetylcholine receptor (AChR) antibody testing is recommended as the first-line diagnostic test, with positive results in approximately 80% of patients with generalized myasthenia gravis but only about 50% of patients with purely ocular myasthenia 4
- Anti-muscle-specific kinase (MuSK) antibody testing should be performed when AChR antibodies are negative, as approximately one-third of seronegative patients will be positive for anti-MuSK antibodies 4
- Single-fiber electromyography (SFEMG) is considered the gold standard diagnostic test with over 90% sensitivity, particularly valuable for ocular myasthenia gravis 4
- Repetitive nerve stimulation testing has lower sensitivity than SFEMG, being positive in only about one-third of patients with ocular myasthenia 4
Bedside Diagnostic Tests
- The ice pack test is highly specific and involves applying an ice pack over closed eyes for 2 minutes to evaluate for improvement in ptosis 4, 1
- The edrophonium (Tensilon) test should be performed in a monitored setting with atropine available due to potential muscarinic side effects 4
Additional Diagnostic Evaluations
- Pulmonary function assessment, including negative inspiratory force and vital capacity measurements, is crucial to evaluate respiratory muscle involvement 4, 1
- Laboratory tests for possible concurrent conditions:
- MRI of brain and/or spine may be needed to rule out alternative diagnoses depending on symptoms 4
Diagnostic Algorithm
- Clinical evaluation for fatigable weakness
- Serological testing:
- Anti-AChR antibodies (first)
- If negative, test for anti-MuSK antibodies
- Electrodiagnostic studies:
- Single-fiber EMG (most sensitive)
- Repetitive nerve stimulation
- Bedside tests:
- Ice pack test
- Edrophonium (Tensilon) test in monitored setting
Important Considerations and Pitfalls
- Avoid medications that can exacerbate myasthenia symptoms during testing, including β-blockers, IV magnesium, fluoroquinolones, aminoglycosides, and macrolides 4, 1
- Myasthenic crisis must be distinguished from cholinergic crisis, as management differs significantly 5
- False-negative antibody tests can occur, particularly in purely ocular myasthenia, making clinical evaluation and electrodiagnostic studies essential 4, 2
- Myasthenia gravis can be associated with thymoma in approximately 20% of patients and with other autoimmune diseases such as hyperthyroidism and Hashimoto's disease 2
Response Patterns to Edrophonium Testing
- Myasthenic response: Increased muscle strength (diagnostic in untreated patients) 5
- Adequate response: No change in muscle strength (seen in treated patients with stabilized therapy) 5
- Cholinergic response: Decreased muscle strength with side effects like lacrimation, diaphoresis, salivation (indicates overtreatment) 5